Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Brookfield Wealth updates market on Just Group acquisition financing

(Sharecast News) - Brookfield Wealth Solutions (BWS) confirmed the successful syndication of a majority of Royal Bank of Canada's commitments under the financing arrangements for its planned acquisition of Just Group on Friday. The acquisition, first announced on 31 July, will see Bidco, a wholly owned subsidiary of BWS, purchase the entire issued and to be issued share capital of Just by way of a court-sanctioned scheme of arrangement. Just published its scheme document on 26 August.

In connection with the deal, Bidco entered into a term credit agreement and a bridge credit agreement with Royal Bank of Canada on 30 July, with RBC Capital Markets acting as lead arranger and bookrunner.

Those agreements had now been amended following syndication through amendment and assignment agreements signed on 28 August.

Under the revised terms, the facilities included a credit adjustment spread for dollar-denominated loans, an additional 0.05% structuring fee on certain bridge loan commitments, and other clarifications covering lender titles and Bidco's obligations regarding ranking of the credit facilities.

BWS said All other key terms remaineed unchanged from those set out in the original announcement and scheme document.

At 1043 BST, shares in Just Group were flat at 211p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.